Articles published by Johnson & Johnson

< Previous 1 2 3 4 5 Next >

Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2023

October 19, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Reports Q3 2023 Results

October 17, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

September 18, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Marks New Era as Global Healthcare Company With Updated Visual Identity

September 14, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation

August 30, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Announces Final Results of Exchange Offer and Finalizes Separation of Kenvue Inc.

August 23, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

August 22, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Announces Preliminary Results of Kenvue Inc. Exchange Offer

August 21, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Announces Final Exchange Ratio of 8.0324 in Split-Off of Kenvue Inc.

August 16, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the 2023 Wells Fargo Securities Healthcare Conference

August 07, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Launches Exchange Offer for Separation of Kenvue Inc.

July 24, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2023

July 20, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Reports Q2 2023 Results

July 20, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the UBS MedTech, Tools and Genomics Summit

July 10, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

June 06, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

May 10, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering

May 03, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the Bernstein 39th Annual Strategic Decisions Conference

April 25, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Announces Launch of Kenvue Inc. IPO Roadshow

April 24, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Announces Dividend Increase of 5.3%

April 18, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Reports Q1 2023 Results

April 18, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Subsidiary LTL Management LLC (“LTL”) Re-Files for Voluntary Chapter 11 to Equitably Resolve All Current and Future Talc Claims

April 04, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Host Investor Conference Call on First-Quarter Results

March 15, 2023

From Johnson & Johnson

Via Business Wire

Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature

March 15, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Announces Pricing of $7.75 Billion of Senior Notes Issued by Kenvue Inc.

March 08, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to its Board of Directors

February 14, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the Barclays Global HealthCare Conference

February 14, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D

February 13, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the Cowen 43rd Annual HealthCare Conference

February 02, 2023

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Reports Q4 and Full-Year 2022 Results

January 24, 2023

From Johnson & Johnson

Via Business Wire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Articles published by Johnson & Johnson